Based on evidence from a publicly available database of melanoma tumor antigen-specific TCR sequences, a previous study determined TCR clonotype clusters and found a marked enrichment of convergent TCR clusters in the CD39+PD-1+ subpopulation of CD4+ and CD8+ TILs (84). This evidence concerns the gene ENTPD1 and melanoma.